Evaluation of Oncolytic Virus-Induced Therapeutic Tumor Vaccination Effects in Murine Tumor Models

Area of Science:

• Immunology
• Oncology
• Virology

Background:

• Oncolytic virotherapy leverages oncolytic viruses (OVs) for cancer treatment.
• The immunostimulatory effects of OVs are critical for their therapeutic efficacy.
• OV-mediated tumor cell lysis releases antigens, activating a tumor-specific immune response.

Purpose of the Study:

• To describe methods for evaluating the therapeutic tumor vaccination effect of OVs in murine models.
• To provide protocols for assessing in vivo and in vitro immune responses to OV therapy.

Main Methods:

• Tumor rechallenge experiments in vivo.
• In vitro splenocyte restimulation assays.
• Flow cytometry analysis of memory T cell populations in tumor-draining lymph nodes.

Main Results:

• The study provides established protocols for evaluating OV-induced anti-tumor immune responses.
• Methods allow for the assessment of systemic and tumor-specific immunity post-OV therapy.

Conclusions:

• Oncolytic virotherapy can be considered a therapeutic cancer vaccination strategy.
• The described methods are essential for characterizing the immune-mediated efficacy of OVs.